Bloomage BioTechnology Corporation Limited (SHA:688363)

SHA:688363 Revenue

Bloomage BioTechnology Corporation had revenue of 839.84M CNY in the quarter ending September 30, 2026, a decrease of -6.96%. This brings the company's total for the last twelve months to 3.63B, down -22.06% year-over-year. In the year 2025, Bloomage BioTechnology Corporation had annual revenue of 4.20B, down -21.82%. That makes Bloomage BioTechnology Corporation the 10,798th largest company in the world by revenue and 1,793rd in China.

• Revenue (ttm): 3.63B
• Revenue Growth: -22.06%
• P/S Ratio: 4.58
• Revenue / Employee: 993.36K
• Employees: 3,656
• Market Cap: 16.76B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Mainland China 5.26B 91.9%
• Other Countries or Regions 402.77M 7.0%
• Hong Kong 60.21M 1.1%

Fiscal year ended Dec 31, 2025 See the full SHA:688363 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.20B	-1.17B	-21.82%
Dec 31, 2024	5.37B	-705.15M	-11.61%
Dec 31, 2023	6.08B	-283.27M	-4.45%
Dec 31, 2022	6.36B	1.41B	28.53%
Dec 31, 2021	4.95B	2.32B	87.93%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error